Progression to hypertension in the non-hypertensive participants in the Flemish Study on Environment, Genes and Health Outcomes

Journal of Hypertension

Volumn 24, Issue 9, 2006, Pages 1719-1727

  Zhang, Haifeng ^a,b   Thijs, Lutgarde ^a   Kuznetsova, Tatiana ^a   Fagard, Robert H ^a   Li, Xinli ^b   Staessen, Jan A ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Blood pressure; General population; Hypertension; Prospective study

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; COHORT ANALYSIS; DISEASE COURSE; ENVIRONMENTAL FACTOR; FEMALE; GENETICS; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR;

EID: 33747449268     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000242395.07473.92     Document Type: Article

References (45)

1. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy WD. Assessment of frequency to progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682-1686.
2. The Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157:2413-2446.
3. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
4. Chobanian AV, Bakris GL, Black BK, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
5. Hemmelgarn BR, Zarnke KB, Campbell NR, Feldman RD, McKay DW, McAlister FA, et al. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure management, diagnosis and assessment of risk. Can J Cardiol 2004; 20:31-40.
6. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres MR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289:2363-2369.
7. Staessen JA, Roels HA, Emelianov D, Kuznetsova T, Thijs L, Vangronsveld J, et al. Environmental exposure to cadmium, forearm bone-density, and risk of fractures: prospective population study. Lancet 1999; 353:1140-1144.
8. Li Y, Thijs L, Kuznetsova T, Zagato L, Struijker-Boudier H, Bianchi G, et al. Cardiovascular risk in relation to α-adducin Gly460Trp polymorphism and systolic pressure. A prospective population study. Hypertension 2005; 46:527-532.
9. Staessen JA, Bieniaszewski L, Pardaens K, Petrov V, Thijs L, Fagard R. Life style as a blood pressure determinant. J Royal Soc Med 1996; 89:484-489.
10. Astrand PO, Rodahl K. Textbook of work physiology. Physiological bases of exercise. New York, NY, USA: McGraw-Hill Book Company; 1986.
11. American Diabetes Association. Screening for type 2 diabetes. Diabet Care 1999; 22 (suppl 1):S20-S23.
12. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114:555-576.
13. Laboratorium voor Antropogenetica, Vrije Universiteit Brussel, Brussels, Belgium. Growth Charts Flanders 2004 (Accessed 6 November 2005. at http://www.vub.ac.be/groeicurven/english.html.).
14. Kannel WB, Gordon T. Evaluation of cardiovascular risk in the elderly: the Framingham study. Bull N Y Acad Med 1978; 54:573-591.
15. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
16. Staessen JA, Gasowski J, Wang JG, Thijs L, Den HE, Boissel JP, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-872.
17. Carbajal HA, Salazar MR, Rionder B, Quaini SM, Rechifort VE, Rodrigo HF, et al. Ten-year blood pressure trends in nonhypertensive inhabitants of La Plata, Argentina. Can J Cardiol 1998; 14:917-922.
18. Winegarden CR. From 'prehypertension' to hypertension? Additional evidence. Ann Epidemiol 2005; 15:720-725.
19. Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med 1987; 16:235-251.
20. Cornoni-Huntley J, LaCroix AZ, Havlik RJ. Race and sex differentials in the impact of hypertension in the United States. The National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Arch Intern Med 1989; 149:780-788.
21. Ford ES, Cooper RS. Risk factors for hypertension in a national cohort study. Hypertension 1991; 18:598-606.
22. Leitschuh M, Cupples LA, Kannel W, Gagnon D, Chobanian A. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991; 17:22-27.
23. Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens 1991; 9:217-223.
24. Bakx JC, van den Hoogen HJ, van den Bosch WJ, van Scayck CP, van Ree JW, Thien T, et al. Development of blood pressure and the incidence of hypertension in men and women over an 18-year period: results from the Nijmegen cohort study. J Clin Epidemiol 1999; 52:531-538.
25. Dyer AR, Liu K, Walsh M, Kiefe C, Jacobs DR Jr, Bild DE. Ten-year incidence of elevated blood pressure and its predictors: The CARDIA Study. J Hum Hypertens 1999; 13:13-21.
26. Kawasaki T, Uezono K, Sanefuji M, Utsunomiya H, Fujino T, Kanaya S, et al. A 17-year follow-up study of hypertensive and normotensive male university students in Japan. Hypertens Res 2003; 26:445-452.
27. Radi S, Lang T, Lauwers-Cances V, Chatellier G, Fauvel JP, Larabi L, et al. One-year hypertension incidence and its predictors in a working population: the IHPAF study. J Hum Hypertens 2004; 18:487-494.
28. Julius S, Nesbitt SD, Egan BM, Weber MA, Michelson EL, Kaciroti N, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006; 354:1685-1697.
29. Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
30. Rosengren A, Eriksson H, Larsson B, Svardsudd K, Tibblin G, Welin L, et al. Secular changes in cardiovascular risk factors over 30 years in Swedish men aged 50: the study of men born in 1913, 1923, 1933 and 1943. J Intern Med 2000; 247:111-118.
31. Kannel WB, Garrison RJ, Dannenberg AL. Secular blood pressure trends in normotensive persons: the Framingham Study. Am Heart J 1993; 125:1154-1158.
32. Wu M, Ware JH, Feinleib M. On the relation between blood pressure change and initial value. J Chron Dis 1980; 33:637-644.
33. Droyvold WB, Midthjell K, Nilsen TI, Holmen J. Change in body mass index and its impact on blood pressure: a prospective population study. Int J Obes (Lond) 2005; 29:650-655.
34. Zhang J, Kesteloot H. Anthropometric, lifestyle and metabolic determinants of resting heart rate. A population study. Eur Heart J 1999; 20:103-110.
35. Stolarz K, Staessen JA, Kuznetsova T, Tikhonoff V, State D, Babeanu S, et al. Host and environmental determinants of heart rate and heart rate variability in four European populations. J Hypertens 2003; 21:525-535.
36. Benowitz NL, Sharp DS. Inverse association between serum cotinine and blood pressure. Circulation 1989; 80:1309-1312.
37. Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street? Hypertension 2000; 35:807-813.
38. Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S. Relationship of tachycardia with high blood pressure and metabolic abnormalities. A study with mixture analysis in three populations. Hypertension 1997; 30:1267-1273.
39. Palatini P, Vriz O, Nesbitt S, Amerena J, Majahalme S, Valentini M, et al. Parenteral hyperdynamic circulation predicts insulin resistance in offspring. Hypertension 1999; 33:769-774.
40. Staessen JA, Lijnen P, Thijs L, Fagard R. Salt and blood pressure in community-based intervention trials. Am J Clin Nutr 1997; 65 (2 suppl): 661S-670S.
41. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, et al. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995; 1:1009-1016.
42. Graudal NA, Galloe AM, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride: a meta-analysis. JAMA 1998; 279:1383-1391.
43. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3-10.
44. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8:393-405. (Editorial review.)
45. Vasan RS, Levy D. Rates of progression to hypertension among non-hypertensive subjects: implications for blood pressure screening. Eur Heart J 2002; 23:1067-1070.